Journal of Clinical Anesthesia
Volume 21, Issue 6 , Pages 442-443 , September 2009

Dexmedetomidine supplemented with local anesthesia for awake laryngoplasty

  • Basem Abdelmalak, MD (Staff Anesthesiologist)

      Affiliations

    • Departments of General Anesthesiology and Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    • Corresponding Author InformationCorresponding author. Department of General Anesthesiology/E31, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA. Tel.: +1 216 444 3746; fax: +1 216 444 2294.
  • ,
  • Larina Gutenberg, DO (Resident)

      Affiliations

    • Departments of General Anesthesiology and Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH 44195, USA
  • ,
  • Robert R. Lorenz, MD (Staff Surgeon)

      Affiliations

    • Department of Otolaryngology-Head and Neck, Department of Otolaryngology, Cleveland Clinic, Cleveland, OH 44195, USA
  • ,
  • Michael Smith, MD (Staff Anesthesiologist)

      Affiliations

    • Departments of General Anesthesiology and Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH 44195, USA
  • ,
  • Ehab Farag, MD (Staff Anesthesiologist)

      Affiliations

    • Departments of General Anesthesiology and Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH 44195, USA
  • ,
  • D. John Doyle, MD, PhD (Staff Anesthesiologist)

      Affiliations

    • Departments of General Anesthesiology and Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH 44195, USA

Received 8 January 2008 ,Revised 31 October 2008 ,Accepted 10 November 2008.

References 

  1. Hartl DM, Travagli JP, Leboulleux S, Baudin E, Brasnu DF, Schlumberger M. Clinical review: current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgery. J Clin Endocrinol Metab. 2005;90:3084–3088
  2. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–705
  3. Maze M. Pharmacology and use of Alpha-2 agonists in anaesthesia. In: European Society of Anaesthesiologists Refresher Course Lectures. 9RC1:Brussels, Belgium: European Society of Anaesthesiology; 2003;p. 83–87
  4. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–394
  5. Scher CS, Gitlin MC. Dexmedetomidine and low dose ketamine provide adequate sedation for awake fiberoptic intubation. Can J Anaesth. 2003;50:607–610
  6. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125–1133
  7. Ramsay MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004;101:787–790

PII: S0952-8180(09)00210-4

doi: 10.1016/j.jclinane.2008.11.009

Journal of Clinical Anesthesia
Volume 21, Issue 6 , Pages 442-443 , September 2009